Get the Stockscreener App
678.39
1.97%
13.09
Pre-market:
680.00
1.61
+0.24%
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $678.39, with a volume of 2.08M.
It is up +1.97% in the last 24 hours and up +7.90% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$665.30
Open:
$660.91
24h Volume:
2.08M
Relative Volume:
1.02
Market Cap:
$250.83B
Revenue:
$45.20B
Net Income/Loss:
$6.87B
P/E Ratio:
37.30
EPS:
18.1888
Net Cash Flow:
$6.75B
1W Performance:
+3.05%
1M Performance:
+7.90%
6M Performance:
+38.37%
1Y Performance:
+44.96%
1-Day Range:
$655.95
$682.98
1-Week Range:
$646.80
$682.98
52-Week Range:
$435.27
$682.98
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
678.39 | 250.83B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
223.77 | 157.31B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
408.79 | 58.92B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.84 | 48.73B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
275.02 | 45.27B | 16.63B | 1.39B | 2.12B | 8.0674 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Initiated | DZ Bank | Buy |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher Scientific stock rises 1.64 percent ahead of the open - AD HOC NEWS
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Stock Hits Record High: What's Happening? - Benzinga
Dodge and Cox’s Bullish Stance on Thermo Fisher Scientific (TMO) - finance.yahoo.com
Thermo Fisher Scientific stock hits 52-week high at 671.69 USD - Investing.com Canada
Thermo Fisher Scientific stock gains 1.03 percent on results - AD HOC NEWS
Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher - finance.yahoo.com
Biodesix advances MRD testing programs with Bio-Rad, Thermo Fisher - Investing.com
Thermo Fisher Scientific (TMO) Launches Gibco CHO K1 Panel On A Fair Value Question - finance.yahoo.com
Biodesix Announces Progress on Tumor-Informed and Tumor-Naïve MRD Programs with Bio-Rad and Thermo Fisher - Quiver Quantitative
Global Automated and Closed Cell Therapy Processing Systems Market Set for Expansion as Scalable Workflows Drive Growth, 2026-2033 - GlobeNewswire Inc.
Thermo Fisher Scientific (TMO) Rolls Out New Media Panel For Biologics Development - finance.yahoo.com
Thermo Fisher Scientific stock gains before the bell - AD HOC NEWS
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher Scientific stock gains at the close - AD HOC NEWS
Thermo Fisher, Bird, BRS at 52-Week Highs on News - baystreet.ca
Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development - BioSpace
Thermo Fisher launches CHO-K1 cell culture media panel By Investing.com - Investing.com Canada
Thermo Fisher Scientific stock holds near its yearly high - AD HOC NEWS
Thermo Fisher Scientific stock slips 0.20 percent ahead of the open - AD HOC NEWS
Thermo Fisher stock rises 0.30 percent at the close - AD HOC NEWS
Transport Media Market Is Going to Boom with Thermo Fisher - openPR.com
Top 3 Health Care Stocks That May Keep You Up At Night This Month - Benzinga
Thermo Fisher Scientific stock rises 1.23 percent near its yearly high - AD HOC NEWS
Thermo Fisher Scientific stock heads into the open after a 0.51 percent gain - AD HOC NEWS
Thermo Fisher Scientific Inc. stock rises Monday, still underperforms market - MarketWatch
Here's How Much $1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today - Benzinga
Mayo Clinic, Thermo Fisher partner to create biomedical database - Healthcare Dive
Mayo Clinic, Thermo Fisher partner to create Precure - MedTech Dive
Thermo Fisher Scientific stock gains as investors eye upcoming earnings and dividend - AD HOC NEWS
Goldman Sachs Adjusts PT on Thermo Fisher Scientific to $780 From $650, Maintains Buy Rating - marketscreener.com
Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating the Market with Strong Buy Ratings and Robust Revenue Growth - DirectorsTalk Interviews
Thermo Fisher stock ends the day higher at the close on the NYSE - AD HOC NEWS
Thermo Fisher Scientific stock eases after guidance raise and solid second-quarter growth - AD HOC NEWS
Thermo Fisher Scientific to Present at the Morgan Stanley 24th An - The National Law Review
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher Scientific (TMO) is Positioned for Resurgence - finance.yahoo.com
Shapiro Administration Highlights the Need for Funding to Grow Pennsylvania’s Innovation Economy During Visit to Thermo Fisher Scientific in Dauphin County - PA Department of Community & Economic Development (.gov)
What Makes Thermo Fisher Scientific (NYSE) Worth Watching Now? - kalkinemedia.com
Three Analysts, Three Verdicts on Thermo Fisher: Here’s Who the Numbers Favor - Yahoo Finance
Why Is Thermo Fisher Scientific (TMO) Building A Massive Early Disease Data Platform? - finance.yahoo.com
Thermo Fisher Sees Stronger Demand, Calls 2026 an ‘Outstanding Year’ - Yahoo Finance
The Zacks Analyst Blog Highlights Cisco, Lam, Thermo Fisher Scientific, Ampco-Pittsburgh and Catalyst - finance.yahoo.com
A Look at Thermo Fisher Scientific Inc (TMO) After 4.5% Gain -- GF Value $598.67 vs Price $641.39 - GuruFocus
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.44% on Sep 15: Facts Behind the Movement - TradingKey
Mayo Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appear - Mayo Clinic News Network
About Thermo Fisher Scientific rStock - Coinbase
Thermo Fisher Scientific Inc. (TMO) latest stock news and headlines - Yahoo Finance UK
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MarketWatch
Thermo Fisher stock gains on UBS upgrade and solid Q2 growth - ad-hoc-news.de
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):